nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—CHRM4—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.03	0.035	CbGpPWpGaD
Hyoscyamine—CHRM4—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0256	0.0298	CbGpPWpGaD
Hyoscyamine—CHRM4—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0248	0.0289	CbGpPWpGaD
Hyoscyamine—Dexmethylphenidate—SLC6A3—Gilles de la Tourette syndrome	0.0248	0.301	CrCbGaD
Hyoscyamine—Methylphenidate—SLC6A3—Gilles de la Tourette syndrome	0.0248	0.301	CrCbGaD
Hyoscyamine—CHRM4—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0231	0.027	CbGpPWpGaD
Hyoscyamine—CHRM4—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0215	0.0251	CbGpPWpGaD
Hyoscyamine—CHRM4—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0209	0.0243	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0202	0.0236	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0202	0.0235	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.02	0.0233	CbGpPWpGaD
Hyoscyamine—CHRM4—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0195	0.0227	CbGpPWpGaD
Hyoscyamine—Cocaine—SLC6A3—Gilles de la Tourette syndrome	0.0188	0.228	CrCbGaD
Hyoscyamine—CHRM1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0173	0.0201	CbGpPWpGaD
Hyoscyamine—CHRM3—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0172	0.02	CbGpPWpGaD
Hyoscyamine—CHRM2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.017	0.0198	CbGpPWpGaD
Hyoscyamine—CHRM1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0167	0.0195	CbGpPWpGaD
Hyoscyamine—CHRM3—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0167	0.0195	CbGpPWpGaD
Hyoscyamine—CHRM2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0165	0.0193	CbGpPWpGaD
Hyoscyamine—CHRM4—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0162	0.0189	CbGpPWpGaD
Hyoscyamine—CHRM1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0156	0.0182	CbGpPWpGaD
Hyoscyamine—CHRM3—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0156	0.0181	CbGpPWpGaD
Hyoscyamine—CHRM2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0154	0.0179	CbGpPWpGaD
Hyoscyamine—CHRM1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0145	0.0169	CbGpPWpGaD
Hyoscyamine—CHRM3—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0145	0.0168	CbGpPWpGaD
Hyoscyamine—CHRM2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0143	0.0167	CbGpPWpGaD
Hyoscyamine—CHRM1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0141	0.0164	CbGpPWpGaD
Hyoscyamine—Benzatropine—SLC6A3—Gilles de la Tourette syndrome	0.0141	0.171	CrCbGaD
Hyoscyamine—CHRM3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.014	0.0164	CbGpPWpGaD
Hyoscyamine—CHRM2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0139	0.0162	CbGpPWpGaD
Hyoscyamine—CHRM4—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0136	0.0159	CbGpPWpGaD
Hyoscyamine—CHRM1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0131	0.0153	CbGpPWpGaD
Hyoscyamine—CHRM3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0131	0.0152	CbGpPWpGaD
Hyoscyamine—CHRM2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0129	0.0151	CbGpPWpGaD
Hyoscyamine—CHRM1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0109	0.0127	CbGpPWpGaD
Hyoscyamine—CHRM3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0109	0.0127	CbGpPWpGaD
Hyoscyamine—CHRM2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0108	0.0126	CbGpPWpGaD
Hyoscyamine—CHRM1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00919	0.0107	CbGpPWpGaD
Hyoscyamine—CHRM3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00916	0.0107	CbGpPWpGaD
Hyoscyamine—CHRM2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00907	0.0106	CbGpPWpGaD
Hyoscyamine—CHRM4—nervous system—Gilles de la Tourette syndrome	0.00883	0.149	CbGeAlD
Hyoscyamine—CHRM4—central nervous system—Gilles de la Tourette syndrome	0.0085	0.143	CbGeAlD
Hyoscyamine—CHRM3—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00764	0.0089	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00757	0.00881	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00742	0.00864	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00734	0.00856	CbGpPWpGaD
Hyoscyamine—CHRM4—brain—Gilles de la Tourette syndrome	0.00675	0.114	CbGeAlD
Hyoscyamine—CHRM4—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00532	0.0062	CbGpPWpGaD
Hyoscyamine—CHRM4—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00517	0.00602	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00494	0.00575	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00484	0.00564	CbGpPWpGaD
Hyoscyamine—CHRM4—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00481	0.00561	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00479	0.00559	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00479	0.00558	CbGpPWpGaD
Hyoscyamine—CHRM2—nervous system—Gilles de la Tourette syndrome	0.00474	0.0799	CbGeAlD
Hyoscyamine—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.00456	0.0769	CbGeAlD
Hyoscyamine—CHRM4—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00447	0.0052	CbGpPWpGaD
Hyoscyamine—CHRM1—nervous system—Gilles de la Tourette syndrome	0.00431	0.0727	CbGeAlD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00423	0.00493	CbGpPWpGaD
Hyoscyamine—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.00415	0.07	CbGeAlD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00411	0.00479	CbGpPWpGaD
Hyoscyamine—CHRM1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00407	0.00474	CbGpPWpGaD
Hyoscyamine—CHRM1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00395	0.0046	CbGpPWpGaD
Hyoscyamine—CHRM3—nervous system—Gilles de la Tourette syndrome	0.00386	0.0651	CbGeAlD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00383	0.00446	CbGpPWpGaD
Hyoscyamine—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.00372	0.0627	CbGeAlD
Hyoscyamine—CHRM1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00368	0.00428	CbGpPWpGaD
Hyoscyamine—CHRM2—brain—Gilles de la Tourette syndrome	0.00362	0.0611	CbGeAlD
Hyoscyamine—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00354	0.00413	CbGpPWpGaD
Hyoscyamine—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00344	0.00401	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00333	0.00388	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00332	0.00387	CbGpPWpGaD
Hyoscyamine—CHRM1—brain—Gilles de la Tourette syndrome	0.0033	0.0556	CbGeAlD
Hyoscyamine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00329	0.00383	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00323	0.00377	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00322	0.00375	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00322	0.00375	CbGpPWpGaD
Hyoscyamine—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.0032	0.00373	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00319	0.00372	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00313	0.00364	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00313	0.00364	CbGpPWpGaD
Hyoscyamine—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00311	0.00363	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00301	0.00351	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.003	0.0035	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00297	0.00346	CbGpPWpGaD
Hyoscyamine—CHRM3—brain—Gilles de la Tourette syndrome	0.00295	0.0498	CbGeAlD
Hyoscyamine—CHRM4—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00291	0.00339	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00285	0.00332	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00284	0.00331	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00282	0.00328	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00277	0.00323	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00276	0.00322	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00273	0.00318	CbGpPWpGaD
Hyoscyamine—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00273	0.00318	CbGpPWpGaD
Hyoscyamine—CHRM3—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00272	0.00317	CbGpPWpGaD
Hyoscyamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00268	0.00312	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00258	0.00301	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00257	0.003	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00255	0.00297	CbGpPWpGaD
Hyoscyamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00244	0.00284	CbGpPWpGaD
Hyoscyamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00243	0.00283	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00217	0.00253	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00217	0.00252	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00214	0.0025	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00211	0.00246	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00211	0.00246	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0021	0.00245	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0021	0.00245	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00208	0.00243	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00208	0.00243	CbGpPWpGaD
Hyoscyamine—CHRM3—Metabolism—HDC—Gilles de la Tourette syndrome	0.00208	0.00242	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00204	0.00238	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00196	0.00229	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00196	0.00228	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00194	0.00226	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00182	0.00212	CbGpPWpGaD
Hyoscyamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00181	0.00211	CbGpPWpGaD
Hyoscyamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.0018	0.0021	CbGpPWpGaD
Hyoscyamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00178	0.00208	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00177	0.00206	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00165	0.00193	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00165	0.00192	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00161	0.00187	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.0015	0.00174	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00138	0.0016	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00137	0.0016	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00136	0.00158	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00123	0.00143	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00122	0.00143	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00121	0.00141	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00119	0.00139	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00119	0.00138	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00118	0.00137	CbGpPWpGaD
Hyoscyamine—CHRM4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00115	0.00134	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00111	0.0013	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00111	0.00129	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00111	0.00129	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00111	0.00129	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.0011	0.00128	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.0011	0.00128	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00108	0.00126	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00108	0.00126	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00107	0.00124	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00105	0.00122	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00101	0.00117	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.001	0.00117	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000995	0.00116	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000977	0.00114	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000948	0.0011	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000883	0.00103	CbGpPWpGaD
Hyoscyamine—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000778	0.000906	CbGpPWpGaD
Hyoscyamine—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000775	0.000903	CbGpPWpGaD
Hyoscyamine—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000768	0.000894	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000706	0.000823	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000704	0.00082	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000697	0.000812	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000659	0.000767	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000656	0.000765	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00065	0.000757	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000639	0.000745	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000637	0.000742	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000631	0.000735	CbGpPWpGaD
Hyoscyamine—CHRM4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000619	0.000721	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000596	0.000694	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000594	0.000692	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000588	0.000685	CbGpPWpGaD
Hyoscyamine—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000417	0.000486	CbGpPWpGaD
Hyoscyamine—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000416	0.000484	CbGpPWpGaD
Hyoscyamine—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000412	0.00048	CbGpPWpGaD
